0000000000363054

AUTHOR

Marc Stadler

0000-0002-7284-8671

showing 3 related works from this author

CRYPTIC SPECIES RELATED TO DALDINIA CONCENTRICA AND D. ESCHSCHOLZII, WITH NOTES ON D. BAKERI

2004

Daldinia macaronesica (from the Canary Islands and Madeira), D. palmensis (from the Canary Islands), D. martinii and D. raimundi (from Sicily), and D. vanderguchtiae (from Jersey, Channel Islands) spp. nov., are described, based on new combinations of teleomorphic and anamorphic characters. They all resemble the pantropical D. eschscholzii and/or the European D. concentrica with regard to teleomorphic characters and secondary metabolite profiles generated by analytical HPLC. The status of the newly described taxa was established by SEM of ascospores and microscopic studies of their anamorphs in comparison with various materials of the aforementioned known species. HPLC and SEM studies on th…

Species complexbiologyXylarialesSettore BIO/02 - Botanica SistematicaHolotypePantropicalPlant SciencePigments BiologicalSpores Fungalbiology.organism_classificationEuropeTaxonChemotaxonomyBotanyDaldinia concentricaGeneticsMicroscopy Electron ScanningTaxonomy (biology)Type specimenMycological Typing TechniquesCryptic species Daldinia AscomycetesEcology Evolution Behavior and SystematicsChromatography High Pressure LiquidBiotechnology
researchProduct

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score.

2022

Immunotherapy with atezolizumab plus bevacizumab represents the new standard of care in systemic front-line treatment of hepatocellular carcinoma (HCC). However, biomarkers that predict treatment success and survival remain an unmet need.Patients with HCC put on PD-(L)1-based immunotherapy were included in a training set (n = 190; 6 European centers) and a validation set (n = 102; 8 European centers). We investigated the prognostic value of baseline variables on overall survival using a Cox model in the training set and developed the easily applicable CRAFITY (CRP and AFP in ImmunoTherapY) score. The score was validated in the independent, external cohort, and evaluated in a cohort of patie…

MaleOncologySorafenibmedicine.medical_specialtyCarcinoma HepatocellularBevacizumabAntineoplastic Agents610 Medicine & healthAntibodies Monoclonal HumanizedAntineoplastic Agents ImmunologicalAtezolizumabGermanyInternal medicinemedicineHumans610 Medicine & healthAgedProportional Hazards ModelsRetrospective StudiesHepatologyProportional hazards modelbusiness.industryLiver NeoplasmsMiddle AgedSorafenibPrognosismedicine.diseaseBevacizumabRegimenTreatment OutcomeItalyHepatocellular carcinomaCohortFemaleImmunotherapyLiver cancerbusinessSwitzerlandmedicine.drug
researchProduct

Concentriols B, C and D, three squalene-type triterpenoids from the ascomycete Daldinia concentrica

2002

Abstract Three squalene-type triterpenoids named concentricols B, C and D ( 1 – 3 ) were isolated from the ethyl acetate extract of fruiting bodies of the xylariaceous ascomycete Daldinia concentrica . Their absolute structures were elucidated by analysis of 2D NMR, MS, IR and UV spectra, and the modified Mosher's method.

SqualeneMagnetic Resonance SpectroscopyMolecular StructureStereochemistrySpectrum AnalysisEthyl acetatePlant ScienceGeneral MedicineHorticultureBiologybiology.organism_classificationBiochemistryTriterpenesSqualenechemistry.chemical_compoundTriterpenoidUv spectraAscomycotachemistryDaldinia concentricaOrganic chemistryMolecular BiologyTwo-dimensional nuclear magnetic resonance spectroscopyPhytochemistry
researchProduct